Pacific Biosciences of California Inc (PACB)
8.935
-0.06
(-0.72%)
USD |
NASDAQ |
Sep 22, 16:00
8.89
-0.04
(-0.50%)
After-Hours: 20:00
Pacific Biosciences of California Net Income (TTM): -319.20M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -319.20M |
| March 31, 2023 | -320.76M |
| December 31, 2022 | -314.25M |
| September 30, 2022 | -299.19M |
| June 30, 2022 | -205.68M |
| March 31, 2022 | -175.29M |
| December 31, 2021 | -181.22M |
| September 30, 2021 | -36.96M |
| June 30, 2021 | -77.21M |
| March 31, 2021 | -59.29M |
| December 31, 2020 | 29.40M |
| September 30, 2020 | -45.62M |
| June 30, 2020 | -51.04M |
| March 31, 2020 | -52.55M |
| December 31, 2019 | -84.13M |
| September 30, 2019 | -114.84M |
| June 30, 2019 | -110.76M |
| March 31, 2019 | -108.71M |
| December 31, 2018 | -102.56M |
| September 30, 2018 | -92.52M |
| June 30, 2018 | -89.50M |
| March 31, 2018 | -92.50M |
| December 31, 2017 | -92.19M |
| September 30, 2017 | -90.46M |
| June 30, 2017 | -85.93M |
| Date | Value |
|---|---|
| March 31, 2017 | -78.89M |
| December 31, 2016 | -74.38M |
| September 30, 2016 | -56.75M |
| June 30, 2016 | -37.44M |
| March 31, 2016 | -30.88M |
| December 31, 2015 | -31.70M |
| September 30, 2015 | -49.26M |
| June 30, 2015 | -60.25M |
| March 31, 2015 | -67.45M |
| December 31, 2014 | -66.16M |
| September 30, 2014 | -64.42M |
| June 30, 2014 | -75.74M |
| March 31, 2014 | -77.08M |
| December 31, 2013 | -79.29M |
| September 30, 2013 | -83.73M |
| June 30, 2013 | -85.97M |
| March 31, 2013 | -87.99M |
| December 31, 2012 | -94.46M |
| September 30, 2012 | -95.62M |
| June 30, 2012 | -102.17M |
| March 31, 2012 | -102.16M |
| December 31, 2011 | -109.39M |
| September 30, 2011 | -122.98M |
| June 30, 2011 | -134.41M |
| March 31, 2011 | -144.65M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-320.76M
Minimum
Mar 2023
29.40M
Maximum
Dec 2020
-136.12M
Average
-105.63M
Median
Net Income (TTM) Benchmarks
| Boston Scientific Corp | 912.00M |
| Abbott Laboratories | 5.161B |
| Integer Holdings Corp | 71.21M |
| Hologic Inc | 484.10M |
| Intellia Therapeutics Inc | -453.44M |